ge: Store at 2°C to 8°C (36°F to 46°F) until opened. After opening, the product may be kept at 2°C to 25°C (36°F to 77°F) for up to 6 weeks. During shipment, the bottle may be maintained at temperatures up to 40°C (104°F) for a period not exceeding 14 days.
17 PATIENT COUNSELING INFORMATION
Handling the Container
Instruct patients to avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions [see Warnings and Precautions (5.1)].
When to Seek Physician Advice
Advise patients that if they develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, they should immediately seek their physician’s advice concerning the continued use of RHOPRESSA.
Use with Contact Lenses
Advise patients that RHOPRESSA contains benzalkonium chloride, which may be absorbed by soft contact lenses. Contact lenses should be removed prior to instillation of RHOPRESSA and may be reinserted 15 minutes following its administration.
Use with Other Ophthalmic Drugs
Advise patients that if more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes between applications.
Missed Dose
Advise patients that if one dose is missed, treatment should continue with the next dose in the evening.
U.S. Patent Nos.: 8,450,344; 8,394,826; 9,096,569; 9,415,043
RHOPRESSA is a registered trademark of Aerie Pharmaceuticals, Inc.
Manufactured for: Aerie Pharmaceuticals, Inc., Irvine, CA 92614, U.S.A.
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL
RHOPRESSA (netarsudil ophthalmic solution) 0.02% label
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL
RHOPRESSA (netarsudil ophthalmic solution) 0.02% sample label
INGREDIENTS AND APPEARANCE
RHOPRESSA
netarsudil solution/ drops
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70727-497
Route of Administration OPHTHALMIC, TOPICAL
Active Ingredient/Active Moiety
Ingredient Name
Basis of Strength
Strength
NETARSUDIL MESYLATE (UNII: VL756B1K0U) (NETARSUDIL - UNII:W6I5QDT7QI) NETARSUDIL MESYLATE 0.285 mg in 1 mL
Inactive Ingredients
Ingredient Name
Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
MANNITOL (UNII: 3OWL53L36A)
BORIC ACID (UNII: R57ZHV85D4)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
WATER (UNII: 059QF0KO0R)
Packaging
#
